NDC product
GOLD LABEL B NUMB
NDC 82617-104 · SCALP TECH INC
Key facts
| Product NDC | 82617-104 |
|---|---|
| Proprietary name | GOLD LABEL |
| Nonproprietary name | LIDOCAINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE |
| Substances | LIDOCAINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE |
| Dosage form | SPRAY |
| Route | TOPICAL |
| Labeler | SCALP TECH INC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M015 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC] and 4 more |
| Marketing start | Feb 23, 2023 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: